Viral Envelope Protein of HTLV-III is the Major Target Antigen for Antibodies in Hemophiliac Patients
1986; Oxford University Press; Volume: 153; Issue: 4 Linguagem: Inglês
10.1093/infdis/153.4.788
ISSN1537-6613
AutoresLynn W. Kitchen, Gianni Marone, Shlomit Orgad, Françis Barin, Rina Zaizov, B. Ramof, Ephraim Gazit, J Kreiss, M. Leal, I. Wichmann, U. Martinowitz, Max Essex,
Tópico(s)T-cell and Retrovirus Studies
ResumoJournal Article Viral Envelope Protein of HTLV-III is the Major Target Antigen for Antibodies in Hemophiliac Patients Get access L. Kitchen, L. Kitchen Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar G. Marone, G. Marone Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar S. Orgad, S. Orgad Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar F. Barin, F. Barin Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar R. Zaizov, R. Zaizov Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar B. Ramof, B. Ramof Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar E. Gazit, E. Gazit Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar J. Kreiss, J. Kreiss Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar M. Leal, M. Leal Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar I. Wichmann, I. Wichmann Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more U. Martinowitz, U. Martinowitz Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Search for other works by this author on: Oxford Academic PubMed Google Scholar M. Essex M. Essex Department of Cancer Biology, Harvard School ofPublic Health, Boston, Massachusetts; Division of Transplantation Immunology and Department ofHematology, The Chaim-Sheba Medical Center, Tel-Hashomer; and Sambur Center for Pediatric Hematology/Oncology, Beilinson Medical Center, Petach-Tiqva, Israel; Division of Infectious Diseases, University of Washington, Seattle, Washington; and the Departments of Medicine and Immunology, Hospital General-Ciudad Sanitaria Virgen del Rocio, Sevilla, Spain Please address requests for reprints to Dr. M. Essex, Department of Cancer Biology, Harvard School of Public Health, 665 Huntington Avenue, Boston, Massachusetts 02115. Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 153, Issue 4, April 1986, Pages 788–790, https://doi.org/10.1093/infdis/153.4.788 Published: 01 April 1986 Article history Received: 12 September 1985 Revision received: 21 November 1985 Published: 01 April 1986
Referência(s)